Researchers pinpoint protein tied to drug resistance in patients with lung cancer

Cancer therapies that target specific genetic abnormalities in tumors have revolutionized treatment possibilities over the past two decades. While quality of life and survival are improved with targeted therapies, relapse is common due to the evolution of new tumor cells that are resistant to the targeted therapy.

Leave A Comment

Your email address will not be published. Required fields are marked *